Questioning the cardiocirculatory excitatory effects of opioids under volatile anaesthesia

British Journal of Anaesthesia

Volumn 93, Issue 3, 2004, Pages 408-413

  Docquier, M A ^a   Lavand'homme, P ^a   Boulanger, V ^a   Collet, V ^a   De Kock, M ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Anaesthetics volatile, sevoflurane; Analgesics opioid, sufentanil; Pain, mechanisms

Indexed keywords

DIZOCILPINE; KETAMINE; KETOROLAC; MELOXICAM; MU OPIATE RECEPTOR; NALOXONE; SEVOFLURANE; SUFENTANIL; AMINO ACID RECEPTOR BLOCKING AGENT; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; HEMODYNAMICS; HYPERALGESIA; INHALATION ANESTHESIA; LOW DRUG DOSE; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; WAKEFULNESS; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; PATHOPHYSIOLOGY; WISTAR RAT;

ANALGESICS, OPIOID; ANESTHETICS, INHALATION; ANIMALS; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; HEMODYNAMIC PROCESSES; HYPERALGESIA; KETAMINE; MALE; METHYL ETHERS; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SUFENTANIL;

EID: 4444370527     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh216     Document Type: Article

References (29)

1. Docquier MA, Lavand'homme P, Lederman C, Collet V, De Kock M. Can determining the minimum alveolar anesthetic concentration of volatile anesthetic be used as an objective tool to assess antinociception in animals? Anesth Analg 2003; 97: 1033-9
2. Crain SM, Shen K. Antagonists of excitatory receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000; 84: 121-31
3. Célèrier E, Laulin J, Larcher A, et al. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res 1999; 91: 1509-20
4. Rivat C, Laulin JP, Corcuff JB, Celerier E, Pain L, Simonnet G. Fentanyl enhancement of carraggeenan-induced long-lasting hyperalgesia in rats: prevention by N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology 2002; 96: 381-91
5. Célèrier E, Rivat C, Jun Y, et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 2000; 92: 465-72
6. Crain SM, Shen K. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasks potent opioid analgesia. Brain Res 2001; 888: 75-82
7. Sotgiu ML, Biella G, Formaglio F, Marchettini P. Central effect of ketorolac involving NMDA receptors activity. Brain Res 1998; 30: 223-6
8. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 7: 1032-36
9. Eger E II, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 1965; 26: 756-63
10. Roizen MF, Horrigan RW, Frazer BM. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision - MAC BAR. Anesthesiology 1981; 54: 390-8
11. Ishizaki K, Yoon D, Yoshida N, Yamazaki M, Arai K, Fujita T. Intrathecal administration of N-methyl-D-aspartate receptor antagonist reduces the minimum alveolar anaesthetic concentration of isoflurane in rats. Br J Anaesth 1995; 75: 636-8
12. Feng J, Kendig JJ. N-methyl-D-aspartate receptors are implicated in hyperresponsiveness following naloxone reversal of alfentanil in isolated rat spinal cord. Neurosci Lett 1995; 189: 128-30
13. Guignard B, Coste C, Costes H, et al. Supplementing desflurane-remifentanil anaesthesia with small dose ketamine reduces peri-operative opioid analgesic requirements. Anesth Analg 2002; 95: 103-8
14. Smith DJ, Pekoe GM, Martin LL, Coalgate B. The interaction of ketamine with the opiate receptor. Life Sci 1980; 26: 789-95
15. Husveit O, Maurset A, Oye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol 1995; 77: 355-9
16. Pekoe GM, Smith DJ. The involvement of opiate and monoaminergic neuronal systems in the analgesia effects of ketamine. Pain 1982; 12: 57-73
17. Tung AS, Yaksh TL. Analgesic effect of intrathecal ketamine in the rat. Reg Anesth Pain Med 1981; 6: 91-4
18. Docquier MA, Lavand'homme P, Collet V, De Kock M. Spinal α2-adrenoceptors are involved in the MACbar sparing effect of systemic clonidine in rats. Anesth Analg 2002: 95: 935-9
19. Maruoka Y, Ohno Y, Tanaka H, et al. Selective depression of spinal polysynaptic reflex by the NMDA receptor antagonists in an isolated spinal cord in vivo. Gen. Pharmacol 1997; 29: 645-9
20. Dickenson AH. Spinal cord pharmacology of pain. Br J Anaesth 1995; 75: 193-200
21. Nadeson R, Tucker E, Bajunaki, Goodchild C. Potentiation by ketamine of fentanyl antinociception. I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems. Br J Anaesth 2002; 88: 685-91
22. Higuchi S, Tanaka N, Shioiri Y, Otomo S, Aihara H. Two modes of analgesic action of aspirin, and the site of analgesic action of salicylic acid. Int J Tissue React 1986; 8: 327-31
23. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 1996; 52: 13-23
24. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136-46
25. Yamamoto T, Nozaki-Taguchi N. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor. Brain Res 1996; 739, 104-10
26. Devoghel JC. Small intrathecal doses of lysine-acetylsalicylate relieve intractable pain in humans. J Int Med Res 1983; 11: 90-1
27. Moss JT, Baysinger CL, Boswell GW, Sayson S. Possible intra-operative anesthetic-sparing effect of parenteral ketorolac. Ann Pharmacother 1992; 26: 922-4
28. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 1996; 93: 2317-21
29. Dildy-Mayfield JE, Adron Harris R. Volatile anesthetic effects at excitatory amino acid receptors in molecular basis of anaesthesia. In: Moody E, Skolnick P, eds Molecular Bases of Anesthesia. Boca Raton, FL: CRC Press, 2001; 231-44